Capricor Therapeutics, Inc.
CAPR
$6.97
$0.081.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.32% | -14.15% | -12.31% | -1,185.15% | 88.07% |
| Total Depreciation and Amortization | 4.01% | 1.20% | 7.69% | 7.74% | 11.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.24% | -4.77% | -34.18% | 75.77% | 7.57% |
| Change in Net Operating Assets | -602.36% | 60.73% | -176.70% | 138.02% | -195.11% |
| Cash from Operations | -27.09% | 5.26% | -868.82% | 89.06% | -31.83% |
| Capital Expenditure | -1,145.25% | 27.07% | 87.82% | 8.90% | -15.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,043.06% | -86.03% | 267.19% | -72.16% | -161.46% |
| Cash from Investing | -6,254.92% | -86.36% | 254.65% | -62.08% | -175.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 20.44% | 3,157.07% | -9.74% | -90.11% | 10,378.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.44% | 3,157.07% | -9.74% | -90.11% | 10,378.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.96% | 1,189.51% | 152.75% | -248.51% | 769.82% |